EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic engineering of Staphylococcus haemolyticus: overcoming restriction-modification barriers and targeting virulence genes

Hermoine J Venter, J Pauline Cavanagh, Runa Wolden, Dakota Jones, Richard J Roberts, Martin O Christensen, Martha Zepeda-Rivera, Christopher D Johnston

Microbial Genomics · 29.07.2026 · 12 (7)

DOI: 10.1099/mgen.0.001780 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Genomics, erschienen am 29.07.2026. Verfasst von Hermoine J Venter und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine, Research Group for Child and Adolescents Health, UiT-The Arctic University of Norway, Tromsø, Norway. Hauptthemen laut MEDLINE: Staphylococcus haemolyticus, DNA Restriction-Modification Enzymes, Genetic Engineering, Virulence Factors. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCR NIH HHS, UiT - The Arctic University of Norway, National Institute of Dental and Craniofacial Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Staphylococcus haemolyticus is an emerging multidrug-resistant nosocomial pathogen noted for robust biofilm formation and complex restriction-modification (RM) systems that hinder genetic manipulation. These barriers have severely limited mechanistic studies into its pathogenesis and immune evasion. Here, we report the development of a molecular toolbox that enables precise genomic engineering of clinical S. haemolyticus isolates. Using PacBio Single-Molecule Real-Time and bisulfite sequencing, we defined the complete genomes and methylomes of nine isolates, generating a functional readout of the active RM defences present in each strain. Among the RM systems identified, a Type II (PDLC03279) and a Type III (PDL3649/PDLC03643) system were significantly overrepresented in clinical isolates, suggesting a potential role in adaptation to host or hospital-associated environments. To bypass these RM barriers, we implemented a dual strategy: first, applying SyngenicDNA-based approaches to eliminate RM target motifs from genetic tools and second, engineering a surrogate Escherichia coli strain (JMC4) to mimic conserved S. haemolyticus methylation patterns. These tools significantly enhanced transformation efficiency and enabled targeted knockout of four putative virulence genes ( sraP, secA2, capA and capI ) as well as allelic exchange of the native capsule operon with the corresponding region from a non-encapsulated isolate. To our knowledge, this is the first report of precise genomic modifications in S. haemolyticus . The establishment of robust molecular tools for transformation and genome editing lays a foundation for future functional studies of virulence and host adaptation in this resilient opportunistic pathogen.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Staphylococcus haemolyticusDNA Restriction-Modification EnzymesGenetic EngineeringVirulence FactorsVirulenceGenome, BacterialHumansEscherichia coliDNA MethylationStaphylococcal Infections

Stichwörter der Autor:innen

DNA methylationStaphylococcus haemolyticusbacterial defence systemsrestriction modification systems

Substanzen

DNA Restriction-Modification EnzymesVirulence Factors

Autor:innen und Institutionen

  • Department of Clinical Medicine, Research Group for Child and Adolescents Health, UiT-The Arctic University of Norway, Tromsø, Norway.
  • Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
  • New England Biolabs, Ipswich, MA, 01938-2723, USA.
  • Genomic Medicine, UT MD Anderson Cancer Center, South Campus Research Building, Houston, TX 77054, USA.

Förderung

  • NIDCR NIH HHS
  • UiT - The Arctic University of Norway
  • National Institute of Dental and Craniofacial Research

Zitieren

APA

Venter, H. J., Cavanagh, J. P., Wolden, R., Jones, D., Roberts, R. J., Christensen, M. O., Zepeda-Rivera, M., & Johnston, C. D. (2026). Genetic engineering of Staphylococcus haemolyticus: overcoming restriction-modification barriers and targeting virulence genes. Microbial Genomics, 12(7). https://doi.org/10.1099/mgen.0.001780

Vancouver

Venter HJ, Cavanagh JP, Wolden R, Jones D, Roberts RJ, Christensen MO, et al. Genetic engineering of Staphylococcus haemolyticus: overcoming restriction-modification barriers and targeting virulence genes. Microbial Genomics. 2026;12(7). doi:10.1099/mgen.0.001780

BibTeX
@article{Venter2026,
  author = {Venter, Hermoine J and Cavanagh, J Pauline and Wolden, Runa and Jones, Dakota and Roberts, Richard J and Christensen, Martin O and Zepeda-Rivera, Martha and Johnston, Christopher D},
  title = {Genetic engineering of Staphylococcus haemolyticus: overcoming restriction-modification barriers and targeting virulence genes},
  journal = {Microbial Genomics},
  year = {2026},
  volume = {12},
  number = {7},
  doi = {10.1099/mgen.0.001780}
}
Kostenlos starten →